Israel Englander Cti Biopharma Corp Transaction History

Millennium Management LLC

  • $207 Billion
  • Q2 2024

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
SELL
$4.2 - $6.01 $16.4 Million - $23.4 Million
-3,896,617 Reduced 81.81%
866,152 $3.64 Million
Q4 2022

Feb 14, 2023
BUY
$4.45 - $6.17 $38,452 - $53,314
8,641 Added 0.18%
4,762,769 $28.6 Million
Q3 2022

Nov 14, 2022
BUY
$5.36 - $7.43 $8.5 Million - $11.8 Million
1,586,041 Added 50.06%
4,754,128 $27.7 Million
Q2 2022

Aug 15, 2022
BUY
$3.55 - $6.27 $3.51 Million - $6.2 Million
989,524 Added 45.42%
3,168,087 $18.9 Million
Q1 2022

May 16, 2022
BUY
$1.9 - $5.23 $3.75 Million - $10.3 Million
1,972,416 Added 956.8%
2,178,563 $10.2 Million
Q4 2021

Feb 14, 2022
SELL
$1.44 - $2.86 $214,490 - $426,002
-148,952 Reduced 41.95%
206,147 $511,000
Q3 2021

Nov 15, 2021
BUY
$2.25 - $3.18 $159,486 - $225,407
70,883 Added 24.94%
355,099 $1.05 Million
Q2 2021

Aug 16, 2021
SELL
$2.16 - $2.62 $326,989 - $396,626
-151,384 Reduced 34.75%
284,216 $711,000
Q1 2021

May 17, 2021
BUY
$2.68 - $3.8 $143,500 - $203,471
53,545 Added 14.01%
435,600 $1.27 Million
Q4 2020

Feb 16, 2021
BUY
$2.48 - $3.8 $947,496 - $1.45 Million
382,055 New
382,055 $1.23 Million
Q3 2020

Nov 16, 2020
SELL
$1.02 - $2.15 $62,013 - $130,715
-60,798 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$0.88 - $1.32 $21,135 - $31,703
24,018 Added 65.3%
60,798 $71,000
Q1 2020

May 14, 2020
BUY
$0.69 - $1.54 $17,873 - $39,892
25,904 Added 238.18%
36,780 $34,000
Q4 2019

Feb 14, 2020
SELL
$0.72 - $1.64 $149,477 - $340,477
-207,608 Reduced 95.02%
10,876 $17,000
Q3 2019

Nov 14, 2019
SELL
$0.64 - $0.92 $301,482 - $433,381
-471,067 Reduced 68.32%
218,484 $181,000
Q2 2019

Aug 14, 2019
BUY
$0.8 - $1.03 $551,640 - $710,237
689,551 New
689,551 $593,000
Q3 2018

Nov 14, 2018
SELL
$1.72 - $5.24 $1.16 Million - $3.55 Million
-676,755 Closed
0 $0
Q2 2018

Aug 14, 2018
SELL
$3.81 - $5.26 $418,444 - $577,695
-109,828 Reduced 13.96%
676,755 $3.37 Million
Q1 2018

May 15, 2018
BUY
$2.7 - $4.06 $2.12 Million - $3.19 Million
786,583 New
786,583 $3.07 Million
Q4 2017

Feb 14, 2018
SELL
$2.47 - $3.34 $166,359 - $224,955
-67,352 Closed
0 $0
Q3 2017

Nov 14, 2017
BUY
$3.12 - $3.65 $210,138 - $245,834
67,352
67,352 $215,000

About CTI BIOPHARMA CORP

CTIC Quotes by TradingView
  • Ticker CTIC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 114,385,000
  • Market Cap $1.04B
  • Description
  • CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients w...
More about CTIC
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email